MCL1 and cancer: Additionally, several studies have implicated MCL-1 as an important mediator of cell survival, in particular in the context of resistance to other anti-cancer drugs including BH3-mimetics.29,39,46 Therefore, additional studies are required to investigate the potential of combining selective BH3-mimetics and assess the potential of MCL-1 as resistance factor.